Table of Content

1. Executive Summary
   1.1. Global Biobetters Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Regulatory Landscape
   3.2. Value Chain Analysis
   3.3. Key Deals and Mergers
   3.4. PESTLE Analysis
   3.5. Porter’s Five Force Analysis
4. Global Biobetters Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
   4.3. Global Biobetters Market Outlook: Product Type
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Product Type, 2018 - 2022
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2023 - 2031
           4.3.3.1. Erythropoietin Biobetters
           4.3.3.2. G-CSF Biobetters
           4.3.3.3. Interferon Biobetters
           4.3.3.4. Insulin Biobetters
           4.3.3.5. Monoclonal Antibodies Biobetters
           4.3.3.6. Anti-haemophilic Factor
           4.3.3.7. Others
   4.4. Market Attractiveness Analysis: Product Type
   4.5. Global Biobetters Market Outlook: Indication
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2018 - 2022
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
           4.5.3.1. Diabetes
           4.5.3.2. Cancer
           4.5.3.3. Renal Disease
           4.5.3.4. Neurodegenerative Disease
           4.5.3.5. Genetic Disorders (Haemophilia)
           4.5.3.6. Others
   4.6. Market Attractiveness Analysis: Indication
   4.7. Global Biobetters Market Outlook: Route of Administration
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Mn) Analysis, By Route of Administration, 2018 - 2022
       4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
           4.7.3.1. Subcutaneous
           4.7.3.2. Intravenous
   4.8. Market Attractiveness Analysis: Route of Administration
   4.9. Global Biobetters Market Outlook: Distribution Channel
       4.9.1. Introduction / Key Findings
       4.9.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2018 - 2022
       4.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
           4.9.3.1. Hospital Pharmacies
           4.9.3.2. Retail Pharmacies
           4.9.3.3. Online Pharmacies
   4.10. Market Attractiveness Analysis: Distribution Channel
5. Global Biobetters Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Biobetters Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       6.2.1. By Country
       6.2.2. By Product Type
       6.2.3. By Indication
       6.2.4. By Route of Administration
       6.2.5. By Distribution Channel
   6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2023 - 2031
       6.4.1. Erythropoietin Biobetters
       6.4.2. G-CSF Biobetters
       6.4.3. Interferon Biobetters
       6.4.4. Insulin Biobetters
       6.4.5. Monoclonal Antibodies Biobetters
       6.4.6. Anti-haemophilic Factor
       6.4.7. Others
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       6.5.1. Diabetes
       6.5.2. Cancer
       6.5.3. Renal Disease
       6.5.4. Neurodegenerative Disease
       6.5.5. Genetic Disorders (Haemophilia)
       6.5.6. Others
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       6.6.1. Subcutaneous
       6.6.2. Intravenous
   6.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       6.7.1. Hospital Pharmacies
       6.7.2. Retail Pharmacies
       6.7.3. Online Pharmacies
   6.8. Market Attractiveness Analysis
7. Europe Biobetters Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       7.2.1. By Country
       7.2.2. By Product Type
       7.2.3. By Indication
       7.2.4. By Route of Administration
       7.2.5. By Distribution Channel
   7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2023 - 2031
       7.4.1. Erythropoietin Biobetters
       7.4.2. G-CSF Biobetters
       7.4.3. Interferon Biobetters
       7.4.4. Insulin Biobetters
       7.4.5. Monoclonal Antibodies Biobetters
       7.4.6. Anti-haemophilic Factor
       7.4.7. Others
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       7.5.1. Diabetes
       7.5.2. Cancer
       7.5.3. Renal Disease
       7.5.4. Neurodegenerative Disease
       7.5.5. Genetic Disorders (Haemophilia)
       7.5.6. Others
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       7.6.1. Subcutaneous
       7.6.2. Intravenous
   7.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       7.7.1. Hospital Pharmacies
       7.7.2. Retail Pharmacies
       7.7.3. Online Pharmacies
   7.8. Market Attractiveness Analysis
8. East Asia Biobetters Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       8.2.1. By Country
       8.2.2. By Product Type
       8.2.3. By Indication
       8.2.4. By Route of Administration
       8.2.5. By Distribution Channel
   8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2023 - 2031
       8.4.1. Erythropoietin Biobetters
       8.4.2. G-CSF Biobetters
       8.4.3. Interferon Biobetters
       8.4.4. Insulin Biobetters
       8.4.5. Monoclonal Antibodies Biobetters
       8.4.6. Anti-haemophilic Factor
       8.4.7. Others
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       8.5.1. Diabetes
       8.5.2. Cancer
       8.5.3. Renal Disease
       8.5.4. Neurodegenerative Disease
       8.5.5. Genetic Disorders (Haemophilia)
       8.5.6. Others
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       8.6.1. Subcutaneous
       8.6.2. Intravenous
   8.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       8.7.1. Hospital Pharmacies
       8.7.2. Retail Pharmacies
       8.7.3. Online Pharmacies
   8.8. Market Attractiveness Analysis
9. South Asia & Oceania Biobetters Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       9.2.1. By Country
       9.2.2. By Product Type
       9.2.3. By Indication
       9.2.4. By Route of Administration
       9.2.5. By Distribution Channel
   9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2023 - 2031
       9.4.1. Erythropoietin Biobetters
       9.4.2. G-CSF Biobetters
       9.4.3. Interferon Biobetters
       9.4.4. Insulin Biobetters
       9.4.5. Monoclonal Antibodies Biobetters
       9.4.6. Anti-haemophilic Factor
       9.4.7. Others
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       9.5.1. Diabetes
       9.5.2. Cancer
       9.5.3. Renal Disease
       9.5.4. Neurodegenerative Disease
       9.5.5. Genetic Disorders (Haemophilia)
       9.5.6. Others
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       9.6.1. Subcutaneous
       9.6.2. Intravenous
   9.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       9.7.1. Hospital Pharmacies
       9.7.2. Retail Pharmacies
       9.7.3. Online Pharmacies
   9.8. Market Attractiveness Analysis
10. Latin America Biobetters Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       10.2.1. By Country
       10.2.2. By Product Type
       10.2.3. By Indication
       10.2.4. By Route of Administration
       10.2.5. By Distribution Channel
   10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2023 - 2031
       10.4.1. Erythropoietin Biobetters
       10.4.2. G-CSF Biobetters
       10.4.3. Interferon Biobetters
       10.4.4. Insulin Biobetters
       10.4.5. Monoclonal Antibodies Biobetters
       10.4.6. Anti-haemophilic Factor
       10.4.7. Others
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       10.5.1. Diabetes
       10.5.2. Cancer
       10.5.3. Renal Disease
       10.5.4. Neurodegenerative Disease
       10.5.5. Genetic Disorders (Haemophilia)
       10.5.6. Others
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       10.6.1. Subcutaneous
       10.6.2. Intravenous
   10.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       10.7.1. Hospital Pharmacies
       10.7.2. Retail Pharmacies
       10.7.3. Online Pharmacies
   10.8. Market Attractiveness Analysis
11. Middle East & Africa Biobetters Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
       11.2.1. By Country
       11.2.2. By Product Type
       11.2.3. By Indication
       11.2.4. By Route of Administration
       11.2.5. By Distribution Channel
   11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2023 - 2031
       11.4.1. Erythropoietin Biobetters
       11.4.2. G-CSF Biobetters
       11.4.3. Interferon Biobetters
       11.4.4. Insulin Biobetters
       11.4.5. Monoclonal Antibodies Biobetters
       11.4.6. Anti-haemophilic Factor
       11.4.7. Others
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Indication, 2023 - 2031
       11.5.1. Diabetes
       11.5.2. Cancer
       11.5.3. Renal Disease
       11.5.4. Neurodegenerative Disease
       11.5.5. Genetic Disorders (Haemophilia)
       11.5.6. Others
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Route of Administration, 2023 - 2031
       11.6.1. Subcutaneous
       11.6.2. Intravenous
   11.7. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2023 - 2031
       11.7.1. Hospital Pharmacies
       11.7.2. Retail Pharmacies
       11.7.3. Online Pharmacies
   11.8. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Amgen Inc.
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. F.Hoffmann-La Roche AG
       12.3.3. Merck & Co. Inc.
       12.3.4. Sanofi SA
       12.3.5. SERVIER
       12.3.6. Porton Biopharma Limited
       12.3.7. Eli Lily and Company
       12.3.8. Novo Nordisk A/S
       12.3.9. Biogen Inc.
       12.3.10. CSL Behring GmbH
       12.3.11. Teva Pharmaceutical Industries Ltd.
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations